Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,022 | -7,977 | -5,981 | -4,187 | -2,229 |
| Depreciation Amortization | 0 | 1 | 0 | 0 | 0 |
| Other Working Capital | 194 | 316 | 116 | 380 | 393 |
| Other Operating Activity | 216 | 1,168 | 697 | 473 | 250 |
| Operating Cash Flow | $-1,612 | $-6,493 | $-5,168 | $-3,335 | $-1,585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 150 | N/A | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | 150 | N/A |
| Other Investing Activity | 0 | 0 | 150 | 0 | 150 |
| Investing Cash Flow | $N/A | $150 | $150 | $150 | $150 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 315 | 8,473 | 5,874 | 5,349 | 51 |
| Financing Cash Flow | $315 | $8,473 | $5,874 | $5,349 | $51 |
| Beginning Cash Position | 5,881 | 3,751 | 3,751 | 3,751 | 3,751 |
| End Cash Position | 4,584 | 5,881 | 4,606 | 5,915 | 2,366 |
| Net Cash Flow | $-1,297 | $2,131 | $856 | $2,165 | $-1,385 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,612 | -6,493 | -5,168 | -3,335 | -1,585 |
| Capital Expenditure | N/A | 150 | N/A | N/A | N/A |
| Free Cash Flow | -1,612 | -6,343 | -5,168 | -3,335 | -1,585 |